4.8 Article

Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.2117630119

关键词

HIV; latency; reservoir; Q4PCR

资金

  1. Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery) [OPOPP1092074, OPP1124068, OPP1168933]
  2. NIH [1UM1 AI100663, R01AI129795]
  3. Einstein-Rockefeller-CUNY Center for AIDS Research [1P30AI124414-01A1]
  4. REACH-HIV Delaney [UM1 AI164565]
  5. Robertson Fund
  6. Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH
  7. Robert S. Wennett Post-Doctoral Fellowship
  8. National Center for Advanced Translational Sciences (National Institutes of Health Clinical and Translational Science Award program) [UL1 TR001866]
  9. Shapiro-Silverberg Fund for the Advancement of Translational Research
  10. Bill and Melinda Gates Foundation [OPP1168933] Funding Source: Bill and Melinda Gates Foundation

向作者/读者索取更多资源

HIV-1 infection leads to the formation of a long-lasting reservoir of latently infected CD4(+) T cells, consisting of intact and defective proviruses. This study used Q4PCR to quantify the reservoir content and found that the defective reservoir remained stable while the intact proviral reservoir decayed over time. Both the intact and defective proviral reservoirs showed dynamic changes, with an enrichment of intact proviruses in expanded CD4(+) T cell clones and a decrease in overall reservoir complexity.
HIV-1 infection produces a long-lived reservoir of latently infected CD4(+) T cells that represents the major barrier to HIV-1 cure. The reservoir contains both intact and defective proviruses, but only the proviruses that are intact can reinitiate infection upon cessation of antiretroviral therapy (ART). Here we combine four-color quantitative PCR and next-generation sequencing (Q4PCR) to distinguish intact and defective proviruses and measure reservoir content longitudinally in 12 infected individuals. Q4PCR differs from other PCR-based methods in that the amplified proviruses are sequence verified as intact or defective. Samples were collected systematically over the course of up to 10 y beginning shortly after the initiation of ART. The size of the defective reservoir was relatively stable with minimal decay during the 10-y observation period. In contrast, the intact proviral reservoir decayed with an estimated half-life of 4.9 y. Nevertheless, both intact and defective proviral reservoirs are dynamic. As a result, the fraction of intact proviruses found in expanded clones of CD4(+) T cells increases over time with a concomitant decrease in overall reservoir complexity. Thus, reservoir decay measurements by Q4PCR are quantitatively similar to viral outgrowth assay (VOA) and intact proviral DNA PCR assay (IPDA) with the addition of sequence information that distinguishes intact and defective proviruses and informs reservoir dynamics. The data are consistent with the notion that intact and defective proviruses are under distinct selective pressure, and that the intact proviral reservoir is progressively enriched in expanded clones of CD4(+) T cells resulting in diminishing complexity over time.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost

Frauke Muecksch, Zijun Wang, Alice Cho, Christian Gaebler, Tarek Ben Tanfous, Justin DaSilva, Eva Bednarski, Victor Ramos, Shuai Zong, Brianna Johnson, Raphael Raspe, Dennis Schaefer-Babajew, Irina Shimeliovich, Mridushi Daga, Kai-Hui Yao, Fabian Schmidt, Katrina G. Millard, Martina Turroja, Mila Jankovic, Thiago Y. Oliveira, Anna Gazumyan, Marina Caskey, Theodora Hatziioannou, Paul D. Bieniasz, Michel C. Nussenzweig

Summary: Receiving three doses of an mRNA vaccine can provide protection against the Omicron variant and induce the production of more potent and broader antibodies. This is due to the expansion and evolution of memory B cell clones, particularly the newly emerging clones that target more conserved regions.

NATURE (2022)

Article Immunology

Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans

Alice Cho, Frauke Muecksch, Zijun Wang, Tarek Ben Tanfous, Justin DaSilva, Raphael Raspe, Brianna Johnson, Eva Bednarski, Victor Ramos, Dennis Schaefer-Babajew, Irina Shimeliovich, Juan P. Dizon, Kai-Hui Yao, Fabian Schmidt, Katrina G. Millard, Martina Turroja, Mila Jankovic, Thiago Y. Oliveira, Anna Gazumyan, Christian Gaebler, Marina Caskey, Theodora Hatziioannou, Paul D. Bieniasz, Michel C. Nussenzweig

Summary: The article discusses the antibody immune response to the Ad26.COV2.S vaccine and mRNA vaccines after a single dose. It highlights that Ad26.COV2.S vaccination induces fewer memory B cells compared to mRNA vaccines, but the potency and breadth of the immune response are comparable. The Ad26.COV2.S vaccine also shows lower levels of neutralizing antibodies and limited efficacy against infection, especially during the Omicron surge.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Immunology

Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants

Marianna Agudelo, Frauke Muecksch, Dennis Schaefer-Babajew, Alice Cho, Justin DaSilva, Eva Bednarski, Victor Ramos, Thiago Y. Oliveira, Melissa Cipolla, Anna Gazumyan, Shuai Zong, Danielle A. S. Rodrigues, Guilherme S. Lira, Luciana Conde, Renato Santana Aguiar, Orlando C. C. Ferreira Jr, Amilcar Tanuri, Katia C. Affonso, Rafael M. Galliez, Terezinha Marta Pereira Pinto Castineiras, Juliana Echevarria-Lima, Marcelo Torres Bozza, Andre M. Vale, Paul D. Bieniasz, Theodora Hatziioannou, Michel C. Nussenzweig

Summary: This paper describes the plasma and memory antibody response in a cohort of SARS-CoV-2 Gamma-infected individuals in Brazil. The results show that potent antibody neutralization is limited to Gamma and Beta variants, with lower neutralizing activity against other variants. Additionally, antibodies elicited by Gamma infection tend to recognize Class 3 epitopes more.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Immunology

Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans

Zijun Wang, Pengcheng Zhou, Frauke Muecksch, Alice Cho, Tarek Ben Tanfous, Marie Canis, Leander Witte, Brianna Johnson, Raphael Raspe, Fabian Schmidt, Eva Bednarski, Justin Da Silva, Victor Ramos, Shuai Zong, Martina Turroja, Katrina G. Millard, Kai-Hui Yao, Irina Shimeliovich, Juan Dizon, Anna Kaczynska, Mila Jankovic, Anna Gazumyan, Thiago Y. Oliveira, Marina Caskey, Christian Gaebler, Paul D. Bieniasz, Theodora Hatziioannou, Michel C. Nussenzweig

Summary: Wang et al. analyze memory B cell and antibody responses in SARS-CoV-2 mRNA vaccines to breakthrough infections with Delta or Omicron BA.1 variants. They found that a third exposure to Delta increases strain-specific memory responses and overall potency and breadth of memory B cells, while a fourth exposure to Omicron BA.1 only increases strain-specific memory responses.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Immunology

Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens

Zijun Wang, Frauke Muecksch, Friederike Muenn, Alice Cho, Shuai Zong, Raphael Raspe, Victor Ramos, Brianna Johnson, Tarek Ben Tanfous, Justin DaSilva, Eva Bednarski, Camila Guzman-Cardozo, Martina Turroja, Katrina G. Millard, Pinkus Tober-Lau, David Hillus, Kai-Hui Yao, Irina Shimeliovich, Juan Dizon, Anna Kaczynska, Mila Jankovic, Anna Gazumyan, Thiago Y. Oliveira, Marina Caskey, Paul D. Bieniasz, Theodora Hatziioannou, Florian Kurth, Leif Erik Sander, Michel C. Nussenzweig, Christian Gaebler

Summary: The study compares antibody immune responses following different COVID-19 vaccination regimens, revealing significant differences that can inform improved vaccination strategies. The findings highlight the importance of vaccine selection in antibody production and protection.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Multidisciplinary Sciences

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells

Eva M. Stevenson, Sandra Terry, Dennis Copertino, Louise Leyre, Ali Danesh, Jared Weiler, Adam R. Ward, Pragya Khadka, Evan McNeil, Kevin Bernard, Itzayana G. Miller, Grant B. Ellsworth, Carrie D. Johnston, Eli J. Finkelsztein, Paul Zumbo, Doron Betel, Friederike Dundar, Maggie C. Duncan, Hope R. Lapointe, Sarah Speckmaier, Nadia Moran-Garcia, Michelle Premazzi Papa, Samuel Nicholes, Carissa J. Stover, Rebecca M. Lynch, Marina Caskey, Christian Gaebler, Tae-Wook Chun, Alberto Bosque, Timothy J. Wilkin, Guinevere Q. Lee, Zabrina L. Brumme, R. Brad Jones

Summary: In a cohort of people with HIV, COVID mRNA vaccination leads to a temporary increase in a specific profile of HIV-specific T-cell responses and a corresponding decrease in residual HIV RNA, indicating productive immune engagement with infected cells.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Distinct gene expression by expanded clones of quiescent memory CD4+ T cells harboring intact latent HIV-1 proviruses

Georg H. J. Weymar, Yotam Bar -On, Thiago Y. Oliveira, Christian Gaebler, Victor Ramos, Harald Hartweger, Gaelle Breton, Marina Caskey, Lillian B. Cohn, Mila Jankovic, Michel C. Nussenzweig

Summary: The study discovered that clones of latent cells carrying dormant HIV-1 viruses mainly exist in a specific subgroup of CD4(+) T cells, which are predominantly T effector memory cells with distinctive gene expression. This finding opens up new possibilities for eradicating HIV-1.

CELL REPORTS (2022)

Article Multidisciplinary Sciences

Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination

Dennis Schaefer-Babajew, Zijun Wang, Frauke Muecksch, Alice Cho, Maximilian Loewe, Melissa Cipolla, Raphael Raspe, Brianna Johnson, Marie Canis, Justin DaSilva, Victor Ramos, Martina Turroja, Katrina G. Millard, Fabian Schmidt, Leander Witte, Juan Dizon, Irina Shimeliovich, Kai-Hui Yao, Thiago Y. Oliveira, Anna Gazumyan, Christian Gaebler, Paul D. Bieniasz, Theodora Hatziioannou, Marina Caskey, Michel C. Nussenzweig

Summary: Feedback inhibition of humoral immunity by antibodies can enhance or inhibit immune responses. However, the influence of pre-existing antibodies on the development of memory B cells is not well understood. By studying individuals who received high-affinity anti-SARS-CoV-2 monoclonal antibodies and mRNA vaccine, it was found that the memory B cells of these individuals had altered characteristics, including expressing low-affinity IgM antibodies and showing epitope masking. This finding may help explain the changes in target profile of memory antibodies after booster vaccinations. Rating: 8.5/10

NATURE (2023)

Article Multidisciplinary Sciences

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape

Leander Witte, Viren A. Baharani, Fabian Schmidt, Zijun Wang, Alice Cho, Raphael Raspe, Camila Guzman-Cardozo, Frauke Muecksch, Marie Canis, Debby J. Park, Christian Gaebler, Marina Caskey, Michel C. Nussenzweig, Theodora Hatziioannou, Paul D. Bieniasz

Summary: The emergence of SARS-CoV-2 variants with neutralizing antibody resistance mutations has led to waves of infection. However, repeated exposure to antigens has also resulted in the production of broadly neutralizing antibodies against these variants. Through their study, Witte et al found that specific substitutions in the spike protein of SARS-CoV-2 enable the acquisition of resistance to broadly neutralizing antibodies. These findings highlight the importance of understanding the interactions between new and old substitutions in the development of antibody escape.

NATURE COMMUNICATIONS (2023)

Article Immunology

CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals

Harry B. Gristick, Harald Hartweger, Maximilian Loewe, Jelle van Schooten, Victor Ramos, Thiago Y. Oliveira, Yoshiaki Nishimura, Nicholas S. Koranda, Abigail Wall, Kai -Hui Yao, Daniel Poston, Anna Gazumyan, Marie Wiatr, Marcel Horning, Jennifer R. Keeffe, Magnus A. G. Hoffmann, Zhi Yang, Morgan E. Abernathy, Kim-Marie A. Dam, Han Gao, Priyanthi N. P. Gnanapragasam, Leesa M. Kakutani, Ana Jimena Pavlovitch-Bedzyk, Michael S. Seaman, Mark Howarth, Andrew T. Mcguire, Leonidas Stamatatos, Malcolm A. Martin, Anthony P. West Jr, Michel C. Nussenzweig, Pamela J. Bjorkman

Summary: Passive transfer of broadly neutralizing anti-HIV-1 antibodies is a strategy to protect against infection, but eliciting these antibodies through vaccination has been challenging. Researchers have successfully induced CD4 binding site (CD4bs) antibody responses using the antibody IOMA, which has potential as a vaccine strategy to generate broadly neutralizing antibodies against HIV-1.

SCIENCE IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

Impact of misclassified defective proviruses on HIV reservoir measurements

Daniel B. Reeves, Christian Gaebler, Thiago Y. Oliveira, Michael J. Peluso, Joshua T. Schiffer, Lillian B. Cohn, Steven G. Deeks, Michel C. Nussenzweig

Summary: Most proviruses in people living with HIV are defective, but intact proviruses can lead to viral rebound. The two-probe intact proviral DNA assay (IPDA) found 40-fold more intact proviruses compared to the near full length (nfl) Q4PCR. Both assays showed that defective proviruses did not decay over 10 years. However, the average half-lives of intact proviruses were different: 108 months for IPDA and 65 months for Q4PCR. Misclassified defective proviruses and very long-lived intact proviruses could explain this difference.

NATURE COMMUNICATIONS (2023)

Article Immunology

Role of affinity in plasma cell development in the germinal center light zone

Mohamed A. Eltanbouly, Victor Ramos, Andrew J. Maclean, Spencer T. Chen, Maximilian Loewe, Sandra Steinbach, Tarek Ben Tanfous, Brianna Johnson, Melissa Cipolla, Anna Gazumyan, Thiago Y. Oliveira, Michel C. Nussenzweig

Summary: We demonstrate in a study using multiple clones that the differentiation of GC B cells into plasma cells depends on affinity, leading to the production of serum responses with high affinity. The study compares GC cells primed for PC differentiation with GC B cells specifically chosen for further affinity maturation. Protective immune responses against various pathogens rely on the development of high-affinity antibody-secreting plasma cells (PCs) in germinal centers (GCs). Transgenic models indicate that there is a strict affinity-based barrier to PC development. However, it is unclear if a similar high-affinity barrier exists in physiological circumstances and the precise nature of the PC fate decision. In this study, we utilize a fate-mapping approach to investigate the relationship between GC B cells selected for additional rounds of affinity maturation, GC pre-PCs, and PCs. The results show that initial PC selection overlaps with GC B cell selection, but the PC compartment accumulates a less diverse collection of higher affinity antibodies over time. Thus, while the GC continues to diversify, affinity-based pre-PC selection filters the GC to allow for the accumulation of a more restricted group of high-affinity antibody-secreting PCs.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

暂无数据